Unique ID issued by UMIN | UMIN000041986 |
---|---|
Receipt number | R000047905 |
Scientific Title | Safety evaluation test for 4-week continuous intake of foods containing SNR14 in healthy volunteers |
Date of disclosure of the study information | 2020/10/02 |
Last modified on | 2021/05/06 09:37:51 |
Safety evaluation test for 4-week continuous intake of foods containing SNR14 in healthy volunteers
Safety evaluation test for 4-week continuous intake of foods containing SNR14 in healthy volunteers
Safety evaluation test for 4-week continuous intake of foods containing SNR14 in healthy volunteers
Safety evaluation test for 4-week continuous intake of foods containing SNR14 in healthy volunteers
Japan |
Healthy Volunteer
Adult |
Others
NO
Evaluate the safety of healthy volunteers by continuously intake of foods containing SNR14.
Safety
(Safety evaluation)
Blood test items,urinalysis items,general physical findings (subjective symptoms,objective findings),vital signs(blood pressure,pulse rate),physical measurements(body weight,body fat percentage,lean body mass),frequency of adverse events
(Measurement item)
Urinary excretion of SNR14,Plasma concentration of SNR14
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
4-weeks intake of SNR14-containing food
4-weeks intake of the placebo food
20 | years-old | <= |
79 | years-old | >= |
Male and Female
1)Subjects who have obtained written consent for participation in the research.
2)Healthy men and women between 20 and 79.
3)Subject who can take meals, eat test foods, etc., take blood samples, take urine samples, and stay quiet and rest on the schedule indicated by investigators.
1)Subjects whose clinical inspection results are outside of the normal range and who are est imated inappropriate to this study.
2)Subjects who had a serious major organ / internal organ or who are currently undergoing treatment and who are estimated inappropriate to this study.
3)As a general rule, those who regularly use drugs for the purpose of treating diseases.
4)Subjects who have allergy.
5)Lactating people, pregnant women or those who may be pregnant, and those who wish to become pregnant during the study period.
6)Subjects who are estimated inappropriate to this study by principal investigator or investigators.
48
1st name | Daisuke |
Middle name | |
Last name | Ochitani |
HUMA R&D CORP
Clinical Development Division
108-0014
Round Cross Tamachi 10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan
03-3431-1260
ochitani@huma-rd.co.jp
1st name | Daisuke |
Middle name | |
Last name | Ochitani |
HUMA R&D CORP
Clinical Development Division
108-0014
Round Cross Tamachi 10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan
03-3431-1260
ochitani@huma-rd.co.jp
HUMA R&D CORP
Otsuka Pharmaceutical Co., Ltd.
Profit organization
AMC Nishi-Umeda Clinic Ethical Review Committee
West Umeda Building 3F 3-3-45 Umeda Kita-ku Osaka Japan,530-0001
06-4797-5660
jimukyoku@amc-clinc.jp
NO
2020 | Year | 10 | Month | 02 | Day |
Unpublished
48
Completed
2020 | Year | 09 | Month | 23 | Day |
2020 | Year | 09 | Month | 24 | Day |
2020 | Year | 10 | Month | 05 | Day |
2020 | Year | 12 | Month | 18 | Day |
2020 | Year | 12 | Month | 24 | Day |
2021 | Year | 01 | Month | 07 | Day |
2021 | Year | 04 | Month | 30 | Day |
2020 | Year | 10 | Month | 02 | Day |
2021 | Year | 05 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047905
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |